EichorEICHOR
Condition: Ros1 Fusion Positive Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Ros1 Fusion Positive

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: RO
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT01639508Description of Neurocognitive and Psychiatric Disorders Associated With Targeted Therapies Used in the Treatment of Lung
Phase N/A · 2 location(s) · Hospices Civils de Lyon · NCT06781905Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors
Phase 1 · 1 location(s) · Guangzhou JOYO Pharma Co., Ltd · NCT06128148A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Xuanzhu Biopharmaceutical Co., Ltd. · NCT04996121Patient-centered, Optimal Integration of Survivorship and Palliative Care
NA · 1 location(s) · Massachusetts General Hospital · NCT04900935Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Phase 3 · 33 location(s) · Nuvation Bio Inc. · NCT07154706Study on the Mechanism of Acquired Resistance of Entrectinib
Phase N/A · 1 location(s) · Fudan University · NCT07199959DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusio
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05770544
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.